BioLine RX Ltd
1 day chart
Kickstart your portfolio with a U.S. stock on us
Sign up and fund a new Wall St account and get a full share randomly chosen between GoPro, Dropbox or Nike.
Sign up and fund a new Wall St account and get a full U.S. share.
T&Cs apply
About BLRX
BioLine RX Ltd is an Israel-based clinical-stage biopharmaceutical company focused on oncology. The Company is commited into in-license novel compounds, develop them through clinical stages, and then partner with pharmaceutical companies for further clinical development andcommercialization. The Company is commited into two projects: Motixafortide (BL-8040), which is a cancer therapy platform , and AGI-134, an immunotherapy treatment.
Find out what a historical investment in BioLine RX Ltd would be worth today using our BLRX stock calculator.
$14.64M
-
0.00%
23.28K
$3.17
$3.01
$3.13
$14.70
$2.30
Ready to start your investing journey with Stake?
Open an accountBLRX FAQs
- Sign up with some I.D. and zero paperwork
- Add funds to your account
- Make your first investment in BLRX
This is not financial product advice nor a recommendation to invest in the securities listed. Past performance is not a reliable indicator of future performance. As always, do your own research and consider seeking financial, legal and taxation advice before investing. No representation is made as to the timeliness, reliability, accuracy or completeness of the market data provided.
Invest in BLRX
on Stake
Buy BLRX from US$3 brokerage
Invest in 9,500+ U.S. stocks and ETFs
Own a slice of BLRX from only US$10 with fractional shares
